Iter-4360dd15-0055-transcript
第 55 轮执行轨迹
→ call search_memory({"limit":10,"query":"4360dd15 NEXT_FOCUS PMID 10 条候选 研究类型 保留 排除 理由"}) → call list_recent({"n":8})
→ call list_by_tag({"limit":20,"tag":"4360dd15"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0051-transcript", "tags": "iteration transcript", "modified": "20260424194527000", "preview": "!! 第 51 轮执行轨迹
→ call search_memory({\"limit\":10,\"query\":\"4360dd15 10 条候选 PMID 题名 研究类型 保留 排除 理由\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0051-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424194527000\", \"preview\": \"!! 第 51 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 PMID 38310895 reference chain Crossref 75 references human trial rapamycin everolimus sirolimus\"}) → call list_recent({\"n\":8}) → call list_tools({}) 【too【tool:list_recent】
{"ok": true, "items": [{"title": "Iter-4360dd15-0054-reflection", "modified": "20260424195244000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424195244000", "tags": "pinned focus"}, {"title": "先用题名锁定原始性", "modified": "20260424195244000", "tags": "lesson evidence-retrieval clinical-trials filtering"}, {"title": "Iter-4360dd15-0054-transcript", "modified": "20260424195237000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0053-reflection", "modified": "20260424194952000", "tags": "iteration reflection"}, {"title": "先定研究原始性再补 PMID", "modified": "20260424194952000", "tags": "lesson evidence-retrieval clinical-trials filtering"}, {"title": "Iter-4360dd15-0053-transcript", "modified": "20260424194945000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0053-final-audit-14-candidates", "modified": "20260424194939000", "tags": "4360dd15 knowledge fact audit clinical-trials"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "Iter-4360dd15-0053-final-audit-14-candidates", "modified": "20260424194939000"}, {"title": "Iter-4360dd15-0052-rapamycin-older-cohort-pmid-mapping", "modified": "20260424194711000"}, {"title": "Iter-4360dd15-0051-secondary-analysis-exclusion-lexicon", "modified": "20260424194517000"}, {"title": "Iter-4360dd15-0050-candidate-audit-originality-check", "modified": "20260424194345000"}, {"title": "Iter-4360dd15-0049-crossref-candidate-overgeneration-critique", "modified": "20260424194224000"}, {"title": "Iter-4360dd15-0048-crossref-trialish-candidate-extraction", "modified": "20260424194106000"}, {"title": "PMID 38310895 access topology verified", "modified": "20260424193545000"}, {"title": "Iter-4360dd15-0042-crossref-family-collapse-10-families", "modified": "20260424192619000"}, {"title": "Iter-4360dd15-0040-crossref-trialish-family-taxonomy", "modified": "20260424192051000"}, {"title": "Iter-4360dd15-0039-crossref-candidate-family-critique", "modified": "20260424191812000"}, {"title": "Critique of Crossref trialish filtering for PMID 38310895 reference chain", "modified": "20260424191745000"}, {"title": "Iter-4360dd15-0038-crossref-human-trial-filter-method", "modified": "20260424191618000"}, {"title": "Iter-4360dd15-0030-vu-research-portal-entry-without-direct-pdf-link", "modified": "20260424185400000"}, {"title": "2024 rapamycin systematic review: abstract-level constraints and what remains missing", "modified": "20260424175824000"}, {"titl
→ call read_note({"title":"Iter-4360dd15-0053-final-audit-14-candidates"})
→ call read_note({"title":"NEXT_FOCUS"})
→ call read_note({"title":"Iter-4360dd15-0054-reflection"})
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0053-final-audit-14-candidates", "tags": "4360dd15 knowledge fact audit clinical-trials", "text": "!! 第 53 轮：14 条候选的最终审计表（PMID、题名、研究类型、保留/排除理由）\n\n本轮目标：把上一轮留下的“剩余 10 条候选”补全为可审计表，并把 4 条已确认的非原始研究并入同一张表，形成完整 14 条清单。\n\n!! 结论\n- 保留：10 条，均可映射到原始临床研究\n- 排除：4 条，标题已明确为 ancillary / follow-up / extension / postextension\n\n!! 可审计表\n| PMID | 题名 | 研究类型 | 决策 | 理由 |\n|---|---|---|---|---|\n| 33977284 | Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials. | phase 2b/3 randomized trials | 保留 | 原始随机试验 |\n| 22367193 | A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults. | 单次给药对照研究 | 保留 | 原始临床药理试验 |\n| 29408453 | A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. | randomized controlled trial | 保留 | 原始随机对照试验 |\n| 22115710 | A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema. | dose-escalation study | 保留 | 原始剂量递增试验 |\n| 35040506 | mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis. | randomized double-blind placebo-controlled futility trial | 保留 | 原始试验 |\n| 25525171 | Intravitreal
【tool:read_note】
{"ok": true, "title": "NEXT_FOCUS", "tags": "pinned focus", "text": "!! 下轮焦点（来自 mission `4360dd15` · Iter-0054）\n\n下一轮必须最窄地攻克剩余 10 条候选的逐条 PMID、研究类型与保留/排除理由补全，并优先排除 extension、follow-up、secondary analysis。"}
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0054-reflection", "tags": "iteration reflection", "text": "!! 本轮进展\n本轮用 PubMed 复核了 29992557、33977284、22367193 三条候选的正式题名与研究形态，继续把“原始临床研究”审计表向可验证状态推进。\n\n!! 失败 / 盲点\n仍未把剩余 10 条候选逐条补齐 PMID、研究类型和保留/排除理由，时间继续消耗在回看轨迹与检索历史上而非完成清单闭环。\n\n!! 下轮焦点\n下一轮必须最窄地攻克剩余 10 条候选的逐条 PMID、研究类型与保留/排除理由补全，并优先排除 extension、follow-up、secondary analysis。\n"}
→ call read_note({"title":"Iter-4360dd15-0051-secondary-analysis-exclusion-lexicon"})
→ call read_note({"title":"Iter-4360dd15-0050-candidate-audit-originality-check"})
→ call read_note({"title":"Iter-4360dd15-0049-crossref-candidate-overgeneration-critique"})
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0051-secondary-analysis-exclusion-lexicon", "tags": "4360dd15 method knowledge evidence-retrieval clinical-trials", "text": "!! 原始临床研究的排除词表：先剔除 secondary / longitudinal / extension 类标题\n\n本轮把 14 条候选中的 4 条非原始研究再次核对并结构化为可复用排除词表。\n\n!! 已确认应排除的标题模式\n- `ancillary study`\n- `follow-up`\n- `extension of a randomized controlled trial`\n- `postextension phase`\n\n!! 典型例子（已在 PubMed 核对到 PMID）\n| PMID | 题名 | 排除理由 |\n|---|---|---|\n| `29806044` | Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study | ancillary |\n| `31781682` | Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial | follow-up |\n| `30564495` | Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial | extension |\n| `34693520` | Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3 | postextension |\n\n!! 可复现的最小判别器\n
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0050-candidate-audit-originality-check", "tags": "4360dd15 knowledge audit evidence-retrieval", "text": "!! 14 条候选的原始性核对结果（第 50 轮）\n\n本轮目标：逐条核对 Crossref 抽出的 14 条候选，保留原始临床研究，并定位误纳入原因。\n\n!! 结论\nCrossref 候选集仍然有效，但其中明确可判定为 非原始研究 的有 4 条：\n\n| 序号 | DOI | 题名片段 | 分类 | 误纳入原因 |\n|---|---|---|---|---|\n| 35 | 10.1016/j.oret.2017.08.015 | Treatment of geographic atrophy with intravitreal sirolimus: the Age-Related Eye Disease Study 2 ancillary study | ancillary | 标题已明确写出 ancillary study，不是独立原始临床试验 |\n| 42 | 10.1155/2019/7684352 | Low-dose sirolimus immunoregulation therapy in patients with active rheumatoid arthritis: a 24-week follow-up ... | follow-up | 标题明确是 24-week follow-up，属于后续随访分析 |\n| 68 | 10.1212/CPJ.0000000000000514 | Everolimus for treatment-refractory seizures in TSC: extension of a randomized controlled trial | extension | 标题明确是 extension of a randomized controlled trial，不是原始入组试验 |\n| 69 | 10.1111/epi.17099 | Adjunctive everolimus therapy ... results from the postextension phase of EXIST-3 | postextension | 标题明确是 postextension phase，属于延伸阶段结果 |\n\n!! 统计\n- 候选总数：14\n- 可判定为原始临床研究：10\n- 明确非原始研究：4\n - follow-up / extension / ancillary = 4\n\n!! 这轮的可复现核对方法\n
\nimport requests, re\nfrom collections import Counter\n\ndoi='10.1016/S2666-7568(23)00258-1'\nmsg=requests.get(f'https://api.crossref.org/works/{doi}', timeout=30,\n headers={'User-Agent':'Mozilla/5.0'}).json()['message']\nrefs=msg['ref【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0049-crossref-candidate-overgeneration-critique", "tags": "4360dd15 lesson evidence-retrieval critical-review", "text": "!! 本轮批判性结论：Crossref 引用链抽取出来的“人类临床候选”仍然过宽\n\n本轮不再继续找 mmc1.pdf 镜像，而是专门检验上一轮的抽取结果是否稳健。结果显示：\n\n- 用 DOI `10.1016/S2666-7568(23)00258-1` 的 Crossref `reference` 数组，按关键词 + trialish 标记过滤后，得到 **14 条**候选，而不是之前口径里的 13 条。\n- 这 14 条里有：\n - `primary/interventional`: 8\n - `follow-up/extension`: 3\n - `ancillary`: 1\n - `unclear`: 2\n- 按疾病/家族粗分，候选明显分散，不全是“抗衰老/健康老龄化”方向，而是混入了：\n - 地理萎缩/眼科\n - 类风湿关节炎\n - 癫痫/TSC\n - 肺动脉高压\n - 肿瘤\n - 甚至健康成人 QT 研究\n\n!! 证伪点\n\n这说明上一轮的规则虽然能复现出“相近数量”的结果，但它**并不能证明** 13 项就是综述的真实纳入项；它只证明了一个更宽的“mTOR/rapalog 人类临床引用集合”。\n\n最大漏洞是：\n- `trialish` 关键词会把 **extension / follow-up / ancillary** 一并吸进来；\n- 仅靠药物名 + 临床试验词，无法区分“综述纳入的原始临床研究”与“后续分析/延长随访”；\n- 也无法区分“与老龄化问题直接相关”与“只是同一药物在其他适应证上的临床试验”。\n\n!! 可复现代码\n
→ call search_memory({"limit":12,"query":"4360dd15 unclear primary interventional family candidate PMID"})
→ call search_memory({"limit":12,"query":"4360dd15 10 条 候选 未补全 PMID 研究类型"})
→ call search_memory({"limit":12,"query":"4360dd15 DOI PMID title mapping crossref family"})
→ call list_by_tag({"limit":20,"tag":"evidence-retrieval clinical-trials"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0051-transcript", "tags": "iteration transcript", "modified": "20260424194527000", "preview": "!! 第 51 轮执行轨迹
→ call search_memory({\"limit\":10,\"query\":\"4360dd15 14 候选 PMID 研究类型 误纳入 original clinical study extension follow-up ancillary\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0048-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424194115000\", \"preview\": \""}, {"title": "Iter-4360dd15-0053-transcript", "tags": "iteration transcript", "modified": "20260424194945000", "preview": "!! 第 53 轮执行轨迹 → call search_memory({\\\""}, {"title": "Iter-4360dd15-0052-transcript", "tags": "iteration transcript", "modified": "20260424194718000", "preview": "!! 第 52 轮执行轨迹 【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0051-transcript", "tags": "iteration transcript", "modified": "20260424194527000", "preview": "!! 第 51 轮执行轨迹
→ call search_memory({\"limit\":10,\"query\":\"4360dd15 14 候选 PMID 研究类型 误纳入 original clinical study extension follow-up ancillary\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0048-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424194115000\", \"preview\": \""}, {"title": "Iter-4360dd15-0037-transcript", "tags": "iteration transcript", "modified": "20260424191347000", "preview": "!! 第 37 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 10 条候选 PMID 题名 研究类型 保留 排除 理由\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"result【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0053-transcript", "tags": "iteration transcript", "modified": "20260424194945000", "preview": "!! 第 53 轮执行轨迹
→ call search_memory({\\\""}, {"title": "Iter-4360dd15-0051-transcript", "tags": "iteration transcript", "modified": "20260424194527000", "preview": "!! 第 51 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 PMID 38310895 reference chain Crossref 75 references human trial rapamycin everolimus sirolimus\"}) → call list_recent({\"n\":8}) → call list_tools({}) 【too【tool:list_by_tag】
{"ok": true, "items": []}
→ call run_python({"code":"titles = {\n33977284: 'Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.',\n22367193: 'A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.',\n29408453: 'A randomized control trial to establish the feasibility and safety of )
【tool:run_python】
{"ok": true, "stdout": "retain 9 exclude 5\nExcluded titles:\n35040506 mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.\n29806044 Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.\n31781682 Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial.\n30564495 Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial.\n34693520 Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3.\n\nPotentially ambiguous retained titles lacking obvious primary markers:\nmiss []\nbuckets {'RCT/controlled': 6, 'phase/pilot/proof-of-concept': 3, 'single-arm/safety': 0, 'other': 0}\n", "stderr": "", "returncode": 0}
→ call pubmed_search({"limit":5,"query":"35040506"})
【tool:pubmed_search】
{"ok": true, "query": "35040506", "results": [{"pmid": "35040506", "title": "mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.", "source": "Mov Disord", "pubdate": "2022 Apr", "authors": ["Palma JA", "Martinez J", "Millar Vernetti P", "Ma T", "Perez MA", "Zhong J", "Qian Y", "Dutta S"], "url": "https://pubmed.ncbi.nlm.nih.gov/35040506/"}]}
→ call search_memory({"limit":8,"query":"4360dd15 35040506 longitudinal analysis randomized placebo futility trial"})
→ call read_note({"title":"Iter-4360dd15-0053-final-audit-14-candidates"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0052-transcript", "tags": "iteration transcript", "modified": "20260424194718000", "preview": "!! 第 52 轮执行轨迹
→ call search_memory({\\\"limi"}, {"title": "Iter-4360dd15-0053-transcript", "tags": "iteration transcript", "modified": "20260424194945000", "preview": "!! 第 53 轮执行轨迹 → call search_memory({\\\""}, {"title": "Iter-4360dd15-0010-transcript", "tags": "iteration transcript", "modified": "20260424175830000", "preview": "!! 第 10 轮执行轨迹 【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0053-final-audit-14-candidates", "tags": "4360dd15 knowledge fact audit clinical-trials", "text": "!! 第 53 轮：14 条候选的最终审计表（PMID、题名、研究类型、保留/排除理由）\n\n本轮目标：把上一轮留下的“剩余 10 条候选”补全为可审计表，并把 4 条已确认的非原始研究并入同一张表，形成完整 14 条清单。\n\n!! 结论\n- 保留：10 条，均可映射到原始临床研究\n- 排除：4 条，标题已明确为 ancillary / follow-up / extension / postextension\n\n!! 可审计表\n| PMID | 题名 | 研究类型 | 决策 | 理由 |\n|---|---|---|---|---|\n| 33977284 | Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials. | phase 2b/3 randomized trials | 保留 | 原始随机试验 |\n| 22367193 | A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults. | 单次给药对照研究 | 保留 | 原始临床药理试验 |\n| 29408453 | A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. | randomized controlled trial | 保留 | 原始随机对照试验 |\n| 22115710 | A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema. | dose-escalation study | 保留 | 原始剂量递增试验 |\n| 35040506 | mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis. | randomized double-blind placebo-controlled futility trial | 保留 | 原始试验 |\n| 25525171 | Intravitreal
→ call pubmed_search({"limit":5,"query":"35040506"})
【tool:pubmed_search】
{"ok": true, "query": "35040506", "results": [{"pmid": "35040506", "title": "mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.", "source": "Mov Disord", "pubdate": "2022 Apr", "authors": ["Palma JA", "Martinez J", "Millar Vernetti P", "Ma T", "Perez MA", "Zhong J", "Qian Y", "Dutta S"], "url": "https://pubmed.ncbi.nlm.nih.gov/35040506/"}]}
→ call write_note({"tags":["4360dd15","lesson","evidence-retrieval","clinical-trials","method"],"text":"!! 题名中的 longitudinal analysis 不能自动判为排除\n\n本轮用 PMID 35040506 复核了一个容易误杀的边界例子：\n\n- 题名：mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.\n- PubMed 结果显示它的正式题名仍然是同一条原始随机试验记录，而不是独立的随访研究。\n\n!! 结论\n)
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\Longitudinal_analysis_is_not_an_automatic_exclusion_in_trial_titles.tid", "title": "Longitudinal analysis is not an automatic exclusion in trial titles"}
【assistant】
本轮完成了一个很窄但重要的修正：我用 PubMed 复核了 **35040506**，确认题名里的 **“1-Year Biomarker Longitudinal Analysis”** 仍然挂在同一条**原始随机安慰剂对照 futility trial** 上，**不能像 follow-up / extension / postextension / ancillary 那样自动排除**。
因此我把这条边界规则沉淀成新知识：
- **可直接排除**：ancillary, follow-up, extension, postextension
- **不要自动排除**：longitudinal analysis（若只是主试验后的附加分析说明）
这比之前的排除词表更稳，能避免误删原始试验。
<NEXT_FOCUS>逐条回扫这 14 条候选标题中的“混合型题名”，只验证哪些后缀是附加分析而不是独立二次研究，先把 exclusion 词表收紧到不会误杀原始试验。</NEXT_FOCUS>
```